Cellebrite DI Ltd.
CLBT
$15.81
-$0.19-1.19%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Net Income | -- | -153.37% | -551.77% | -167.13% | |
| Total Depreciation and Amortization | -- | -0.83% | 2.18% | 3.31% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -- | 151.70% | 2,353.83% | 225.70% | |
| Change in Net Operating Assets | -- | -33.00% | 70.06% | 1,466.41% | |
| Cash from Operations | -- | 51.87% | 128.55% | 395.98% | |
| Capital Expenditure | -- | -40.73% | -0.11% | 24.16% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -95.63% | -23.83% | 79.48% | |
| Cash from Investing | -- | -91.42% | -22.19% | 75.29% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | 22.81% | 84.38% | 55.80% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | -- | 22.81% | 84.38% | 55.80% | |
| Foreign Exchange rate Adjustments | -- | -127.33% | 87.06% | 135.83% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | -118.84% | 187.71% | 274.65% | |